Login
Search Button
Button
Home
My NEI
CNS Spectrums
Store
About NEI
Search
Create Account
Search
View Cart
(0)
Log In
Membership
Membership Information
Sign Up or Renew
Overview
Rates
Groups and Institutions
Download Brochure
Member Benefits
Patient Education
Master Psychopharmacology Program
Stahl's Essential Psychopharmacology, Video Edition
Encore Presentations
NEI Prescribe
Become a Member
My NEI Portal
Meetings
NEI Meetings
Congress
Synapse
Saturday Morning Live
Practice Tools
Practice Tools
NEI Prescribe (Web Access)
NEI Prescribe (Download App)
Prescriber's Guide (PDFs)
Medication Tips and Pearls
Patient Education
Teaching Tools
Teaching Tools
Teaching Videos
Stahl's Essential Teaching Slides and Tests
NEI Teaching Slides
NEI Proctor: Master Psychopharmacology Program
Online CME/CE
By Format
Featured Activities
On Demand Videos
Cases
Articles
Animations
Self-Assessments (MOC)
Certificate Program
By Specialty
Primary Care
Pediatric
My NEI
Browsing articles in "Pain"
 
How Sleep Loss Amplifies Pain
November 20, 2023
Chronic pain, a pervasive condition affecting 11–40% of adults, is often accompanied by anxiety, depression, and sleep disorders. Despite empirical evidence linking disturbed sleep to heightened pain sensitivity, the mechanisms...
Continue reading
(Members only)
New Guidelines for Cannabis in Chronic Pain Management Released
April 20, 2023
In this timely study, researchers performed a systematic review of studies investigating the use of cannabinoid-based medicines (CBM) in the treatment of chronic pain, as well as some of the comorbidities that often accompany chronic pain (such as sleep, anxiety, and depression)...
Continue reading
FDA Approves Ubrogepant for Acute Treatment of Migraine
January 24, 2020
Schizophrenia is a lifelong illness affecting approximately 2.4 milliMigraine, an episodic neurologic condition encompassing headaches, sensitivity to light and sounds, and nausea, affects over 30 million individuals in the United States and is the 2nd leading cause of disability worldwide. Fortunately...
Continue reading
(Members only)
FDA Does Not Approve Sublingual Buprenorphine Spray for Pain
August 13, 2018
The FDA has opted not to approve a new formulation of the opioid medication...
Continue reading
(Members only)
Can Cannabis Use Reduce Opioid Use?
February 9, 2018
Given the ongoing prescription opioid use disorder epidemic as well as the increasing legalization and availability of marijuana, the authors sought to determine whether marijuana use reduced the non-medical use of prescribed opioids...
Continue reading
Increased Risk of Opioid-Related Death in Patients Taking Concomitant Gabapentin
October 16, 2017
A new study examined the increased risk for opioid-related death in patients taking concomitant prescription opioids and gabapentin...
Continue reading
(Members only)
Highlights from the 2017 APA Annual Meeting
June 8, 2017
The 2017 APA annual meeting, held in NEI's hometown of San Diego, was themed "Prevention Through Partnership" and included more than 400 sessions. Here, we provide highlights of the meeting, including NEI's podcast interviews with expert presenters, key research from the poster sessions, and NEI's debut live concert--the NEI PsychopharmaJam.
Continue reading
Report on Health Effects of Cannabis Released by National Academies of Sciences, Engineering, and Medicine
February 3, 2017
With the recent legalization of both medical and recreational use in numerous states across the nation (and an estimated 22 million cannabis users in the United States), there is growing interest regarding the potential benefits and risks associated with marijuana use. It is therefore apropos that the Committee on the Health Effects of Marijuana (as part of the National Academies of Sciences, Engineering, and Medicine) has published a report that reviews the state of existing evidence on both the positive and negative effects of marijuana as well as recommendations for future research...
Continue reading
(Members only)
Increase in Opioid-Related Deaths Not Driven By Prescription Painkillers
January 12, 2017
Opioid abuse remains an epidemic in the United States, with over 50,000 deaths associated with drug overdose, and 63% of those attributed to opioids...
Continue reading
(Members only)
Oral Ketamine Relieves Depression in Patients with Chronic Pain
November 17, 2016
In a six-week randomized, double-blind study, 150 mg of oral ketamine was compared to 150 mg of diclofenac, administered daily to patients with chronic pain...
Continue reading
(Members only)
1
2
Top of Page
Categories
All
Addiction/Reward
Additional Neurology Topics
ADHD
Alzheimer's/Other Dementias
Anxiety/Stress-Related Disorders
Basic Neuroscience
Bipolar Disorders
Brain Injuries
Child Psychiatry
Cognitive Disorders
Eating Disorders
Forensic Psychiatry
Geriatric Psychiatry
OCD
Pain
Personality Disorders
Pregnancy/Postpartum
Professional Improvement
Psychotic Disorders
Sexual Disorder
Side Effects
Sleep
Unipolar Depression